Top Markets
#1 Black Phoenix Black Phoenix +350.33%
#2 Islamic Coin Islamic Coin +158.10%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +21.05%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#6 DOVU DOVU +10.14%
#7 Palladium Network Palladium Network +8.75%
#8 Pons Pons +8.51%
#9 stake.link stake.link +8.17%
#10 COTI COTI +7.25%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
Rang in Aktien #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$4.04K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Xeno Transplants Corporation (XENO)

Kategorie

Healthcare
Kursverlauf für Xeno Transplants Corporation (XENO)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $0.33 am 2006-08-01
Kursverlauf der Aktie von Xeno Transplants Corporation von 2006 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -50.00%
2022 100.00%
2021 -93.74%
2020 -73.43%
2019 102.25%
2018 -7.07%
2017 67.54%
2016 -45.43%
2015 153.29%
2014 -23.64%
2013 -9.52%
2012 -44.74%
2011 -59.79%
2010 332.31%
2009 -85.91%
2008 -96.85%
2007 -72.30%
2006 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -7.46%
KR